While the US Food and Drug Administration has been working to speed up the time it takes for drugs to garner approval, Commissioner Margaret Hamburg says that the sequester may slow those efforts, the Boston Herald reports. Speaking to the Massachusetts Biotechnology Council annual meeting attendees, Hamburg added that she would like Congress to allow FDA to access the user fees it collects to pay for its operating costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.